Frontiers in Oncology | Breast Cancer

Original Research

Published on 02 Feb 2026

Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study

in Breast Cancer

Wei Luo
Yan Dai
Jiahua Wu
Xiaohong Xue
Lifang Liu
Weihe Bian
Xiaohong Xie
Gang Lyu
Ri Hong
Chang Qiu

Frontiers in Oncology

doi 10.3389/fonc.2026.1652339

501 views

Systematic Review

Accepted on 30 Jan 2026

Comparison of the Effects of Cognitive-Supportive-Relaxation Multimodal Psychosocial Intervention on Fear of Cancer Recurrence and Psychological Resilience in Breast Cancer Patients: A Network Meta-Analysis Based on Randomized Controlled Trials

in Breast Cancer

Jiankun Yuan
xiaojuan Li
xiangying Li
xuejun Dai
aihua Deng
lang He

Frontiers in Oncology

Original Research

Accepted on 30 Jan 2026

Prognostic Prediction Model for Triple-Negative Breast Cancer Using Artificial Intelligence and Ultrasound Radiomics

in Breast Cancer

Yushanjiang Zilalan
Jingjing Fan
Tong Sha
Wen Liu
Hongtao Li

Frontiers in Oncology

132 views

Original Research

Published on 30 Jan 2026

Early peritumoral edema change improve prediction of pathological complete response in breast cancer: a multiparametric magnetic resonance imaging-based model

in Breast Cancer

Fuqiang Pan
Yalei Wang
Baoqi Zhang
Yuqing Xin
Heshan Han
Yang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2026.1671985

441 views

Case Report

Published on 30 Jan 2026

Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen

in Breast Cancer

Francesca Piazza
Giulia Scartabellati
Laura Moretti
Marta Laganà
Lucia Vassalli
Benedetta Trevisan
Michela Bazzoli
Greta Schivardi
Federico Canzi
Roberto Baraziol

Frontiers in Oncology

doi 10.3389/fonc.2026.1733621

392 views

Review

Accepted on 29 Jan 2026

Advances in Intratumoral Immunotherapy and from a Neuro-Immune-Endocrine Modulation Perspective for Breast Cancer Treatment

in Breast Cancer

Claudia Angelica Garay-Canales
Mariana Segovia-Mendoza
Yair Rodríguez Santiago
Karen Elizabeth Nava-Castro
María Ríos
Valeria Vargas
Diana Lizeth Ruiz-Antonio
César Antonio Zavala-López
Carmen Gómez De León
Jorge Morales-Montor

Frontiers in Oncology

145 views

Case Report

Accepted on 29 Jan 2026

Co-existence of fibroadenoma, intraductal carcinoma and invasive ductal carcinoma in the unilateral breast mass: a case report and literature review

in Breast Cancer

Sha Zhong
Hui Xu
Xuan Ye
Yi Xu
Zhe Fan

Frontiers in Oncology

Case Report

Published on 29 Jan 2026

HER-2 overexpressing breast cancer during pregnancy: a case report and literature review

in Breast Cancer

Si Li
Tuoshu Huang
Mujin Feng
Minjun Deng
Xiyu Chen
Xinning Li
Dan Mo

Frontiers in Oncology

doi 10.3389/fonc.2026.1725927

621 views

Case Report

Published on 29 Jan 2026

Case Report: Re-irradiation of out-of-field recurrence of malignant phyllodes tumors of the breast after adjuvant radiotherapy

in Breast Cancer

Ziwei Li
Juan Zhong
Yingying Shi
Wenliang Lu
Yanjv Lu
Ning Ge

Frontiers in Oncology

doi 10.3389/fonc.2026.1694960

647 views

Original Research

Published on 29 Jan 2026

The value of multimodal ultrasound imaging in differentiating HER2-positive breast cancer

in Breast Cancer

Yu-Meng Lei
Chen Liu
Bing-Song Lei
Chen Liao
Ning Zhang
Qi Wang
Shu-E Zeng
Ge Zhang
Hua-Rong Ye

Frontiers in Oncology

doi 10.3389/fonc.2026.1718785

462 views

Case Report

Published on 29 Jan 2026

Case Report: Long-term control of brain metastases with over 100 cycles of T-DM1 in HER2-positive metastatic breast cancer

in Breast Cancer

Hyemi Ko
Song-Yi Choi
Donghyun Kim
Jinsun Lee

Frontiers in Oncology

doi 10.3389/fonc.2026.1778267

488 views

Systematic Review

Published on 29 Jan 2026

Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients

in Breast Cancer

Peng Li
Yongting Cheng
Junfeng Zhao
Yuan Fang
Tingting Zhao

Frontiers in Oncology

doi 10.3389/fonc.2026.1666576

396 views

Original Research

Published on 28 Jan 2026

Endocrine regimen and early subclinical atherosclerosis in premenopausal HR+/HER2− breast cancer: real-world evidence and regimen-dependent effects of Sanhuang Decoction

in Breast Cancer

Ke Hong
Cong Wang
Menglei Yang
Mengyue Du
Huanhuan Wang
Jiawei Wu
Xinhe Liu
Xiaoyu Li
Wenjie Wu
Shuqin Li

Frontiers in Oncology

doi 10.3389/fonc.2026.1695776

520 views

Case Report

Published on 28 Jan 2026

Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation

in Breast Cancer

Qiuting You
Longlong Gong
Yi Chen
Xiaoxiao Dinglin
Ziliang Cheng
Qian Xia
Jinxia Xie
Jianli Zhao
Fengxi Su

Frontiers in Oncology

doi 10.3389/fonc.2026.1679086

645 views

Original Research

Published on 27 Jan 2026

ABCA8-positive lipid-metabolic CAFs mediate immunotherapy resistance in TNBC

in Breast Cancer

Weidong Qin
Danxi Li
Jiawei Zhang
Shuning Wang
Lan Hou
Cun Zhang
Donghui Wang
Juliang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1729275

704 views

Original Research

Published on 27 Jan 2026

Impact of quality control indicator system management program on neoadjuvant and adjuvant therapies for breast cancer: a comparative analysis

in Breast Cancer

Silu Xu
Nianyang Ding
Lili Zhang
Sainan Hu
Meixin Ni
Haijuan Gu
Zeng Chen
Zhengzheng Xie
Nan Wu
Yuanyuan Wen

Frontiers in Oncology

doi 10.3389/fonc.2026.1597546

461 views

Original Research

Published on 27 Jan 2026

Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer

in Breast Cancer

Masahiro Ohara
Emi Mikami
Wakako Inohana
Taeko Kurosawa
Ayako Nakame
Ayaka Sakakibara
Yuki Ichinose
Akihiro Fujimoto
Asami Nukui
Aya Asano

Frontiers in Oncology

doi 10.3389/fonc.2026.1677929

568 views

Case Report

Published on 26 Jan 2026

Case Report: Mixed ductal–lobular carcinoma consisting of invasive lobular carcinoma with a glycogen-rich clear cell pattern and elevated tumor mutation burden

in Breast Cancer

Kae Kawachi
Xiaoyan Tang
Rika Kasajima
Kotoe Katayama
Rui Yamaguchi
Kiyoshi Yamaguchi
Yoichi Furukawa
Seiya Imoto
Satoru Miyano
Emi Yoshioka

Frontiers in Oncology

doi 10.3389/fonc.2026.1741727

653 views

Original Research

Published on 26 Jan 2026

Chemotherapy-induced gut microbiota dysbiosis exacerbates cancer-related fatigue in breast cancer patients via neuroimmune-endocrine indicators

in Breast Cancer

Fengxia Lai
Yang Yuan
Haiyan Dong
Daoxia Guo
Zhongfang Yang
Li Tian

Frontiers in Oncology

doi 10.3389/fonc.2026.1710457

711 views

Correction

Published on 26 Jan 2026

Correction: Vitiligo associated with ribociclib therapy: a rare case report

in Breast Cancer

Zirui Wang
Yuanrui Bai
Rihan Wu
Yihui Liu
Chunhui Dong
Ling Chen

Frontiers in Oncology

doi 10.3389/fonc.2026.1790586

299 views

Original Research

Published on 23 Jan 2026

Predicting histological grade in invasive ductal carcinoma of the breast: a radiomics-based machine learning model using DCE-MRI

in Breast Cancer

Ziwen Wang
Chenglin Bai
Naiyou Zhang
Zhipeng Han
Haiming Dong
Shanzheng Liu
Jingjing Meng
Chengjun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1593075

625 views

Systematic Review

Published on 23 Jan 2026

Can radiotherapy be omitted in T1-2N1 breast cancer patients after mastectomy without neoadjuvant therapy?

in Breast Cancer

Jing Hou
Shuangqiang Qian
Chenyi Liao
Chengwen Wu
Xi Zhang
Yanchun Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1726994

678 views

Review

Published on 22 Jan 2026

Optimizing second-line endocrine-based treatment in HR positive HER2 negative metastatic breast cancer: a comprehensive expert statement from the Gulf Cooperation Council Region

in Breast Cancer

Ahmed Alshehri
Abdullah Khalaf Altwairgi
Abdulwahab AlTourah
Ahmed Alwbari
Aref Chehal
Francois Calaud
Hashem Al-Hashem
Husam Marashi
Sherif Elsamany
Syed Hammad Tirmazy

Frontiers in Oncology

doi 10.3389/fonc.2025.1706670

1,418 views

Original Research

Published on 21 Jan 2026

Impact of breast cancer genetic testing in Brazilian patients: insights from the MAGENTA study

in Breast Cancer

Evelin Scarelli
Carolina Meyn Teixeira
Nathália Viana e Silva
Andrea Silveira dos Santos Bredariol
Giovana Sivieri Baracho
Fabiano Hahn Souza
Luciana Holtz

Frontiers in Oncology

doi 10.3389/fonc.2025.1597891

689 views

1,698 articles

articles

Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study

Comparison of the Effects of Cognitive-Supportive-Relaxation Multimodal Psychosocial Intervention on Fear of Cancer Recurrence and Psychological Resilience in Breast Cancer Patients: A Network Meta-Analysis Based on Randomized Controlled Trials

Prognostic Prediction Model for Triple-Negative Breast Cancer Using Artificial Intelligence and Ultrasound Radiomics

Early peritumoral edema change improve prediction of pathological complete response in breast cancer: a multiparametric magnetic resonance imaging-based model

Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen

Advances in Intratumoral Immunotherapy and from a Neuro-Immune-Endocrine Modulation Perspective for Breast Cancer Treatment

Co-existence of fibroadenoma, intraductal carcinoma and invasive ductal carcinoma in the unilateral breast mass: a case report and literature review

HER-2 overexpressing breast cancer during pregnancy: a case report and literature review

Case Report: Re-irradiation of out-of-field recurrence of malignant phyllodes tumors of the breast after adjuvant radiotherapy

The value of multimodal ultrasound imaging in differentiating HER2-positive breast cancer

Case Report: Long-term control of brain metastases with over 100 cycles of T-DM1 in HER2-positive metastatic breast cancer

Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients

Endocrine regimen and early subclinical atherosclerosis in premenopausal HR+/HER2− breast cancer: real-world evidence and regimen-dependent effects of Sanhuang Decoction

Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation

ABCA8-positive lipid-metabolic CAFs mediate immunotherapy resistance in TNBC

Impact of quality control indicator system management program on neoadjuvant and adjuvant therapies for breast cancer: a comparative analysis

Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer

Case Report: Mixed ductal–lobular carcinoma consisting of invasive lobular carcinoma with a glycogen-rich clear cell pattern and elevated tumor mutation burden

Chemotherapy-induced gut microbiota dysbiosis exacerbates cancer-related fatigue in breast cancer patients via neuroimmune-endocrine indicators

Correction: Vitiligo associated with ribociclib therapy: a rare case report

Predicting histological grade in invasive ductal carcinoma of the breast: a radiomics-based machine learning model using DCE-MRI

Can radiotherapy be omitted in T1-2N1 breast cancer patients after mastectomy without neoadjuvant therapy?

Optimizing second-line endocrine-based treatment in HR positive HER2 negative metastatic breast cancer: a comprehensive expert statement from the Gulf Cooperation Council Region

Impact of breast cancer genetic testing in Brazilian patients: insights from the MAGENTA study